Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 323
Selected: 0
NCT IDTitle
NCT03868072Study to Evaluate the Bioequivalence of Pfizer Korea Inc. "XELJANZ 5Mg Tablet" in Healthy Volunteers
NCT01819870Study to Compare the Pharmacokinetic Characteristics and Safety of Dilatrend SR Capsule 32mg and Dilatrend Tablet 25mg
NCT04673695A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344
NCT03770052Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie
NCT03437785Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 Tablet
NCT04224350Study to Evaluate the Efficacy and Safety of Tacrolimus in Kidney Transplant Recipients (BLOSSOM)
NCT02827890CKD-396 Drug-drug Interaction Study(B) (CKD-396 DDI(B) P1)
NCT05526703Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy
NCT05749861A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5)
NCT03431623CKD-11101 Phase 3 SC Study
NCT01501253CKD-828 S-Amlodipine Non-Responder Trial
NCT03150316CKD-581 + Lenalidomide + Dexamethasone in Patients With Previously Treated Multiple Myeloma
NCT01128322CKD-828 Primary Hypertension Trial(Dose-selection)
NCT04083846Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
NCT03382756A Clinical Trial to Assess the Effects of Food on the Bioavailability of CKD-337
NCT02824874CKD-396 Drug-drug Interaction Study(A) (CKD-396 DDI(A) P1)
NCT07215637Phase Ia/Ib Study of CKD-512 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Solid Tumors
NCT02247518CKD-397 Drug-drug Interaction Study (A)
NCT05245084A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(3) 80/20/10mg
NCT05843162A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome
NCT04521023A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy
NCT04805606A Clinical Traial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843
NCT03802162A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355
NCT03739125Efficacy and Safety of CKD-501 Added to D150 Plus D745 10mg Therapy in Patients With Type 2 Diabetes
NCT04334213A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D745 and D150
NCT02615782A Clinical Trial to Evaluate the Effects of Food on the Bioavailability of CKD-397 in Healthy Male Subjects
NCT03849261Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 in Healthy Adults
NCT04388215Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet
NCT02627027A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male Volunteers
NCT04246190A Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-396
NCT06281132Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D956 in Healthy Adults
NCT04676893Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388 in Healthy Subjects
NCT03233932CKD-841 Pharmacokinetic/Pharmacodynamic Study
NCT07304700Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.5/10/1000mg in Healthy Volunteers
NCT06399055Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fasting Conditions
NCT01001611An Evaluation of Glycemic Control Effects of Mono Therapy CKD-501 in Patients With Type 2 Diabetes Mellitus
NCT04623021A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia
NCT06695598Clinical Study to Evaluate the Food Effect of CKD-383 0.5/25/1000mg in Healthy Volunteers
NCT01341392Drug-drug Interaction Study(CKD-501, Amlodipine)
NCT04906798Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions
NCT05347576A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed Conditions
NCT07365358Evaluate the Efficacy and Safety of Empagliflozin or Glimepiride Combination Therapy in Type 2 Diabetes Mellitus Patients
NCT01369472Evaluating Dose-proportionality of Dilatrend Suspended-Release Capsule
NCT07304726Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.25/12.5/1000mg in Healthy Volunteers
NCT03950843A Clinical Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation
NCT06942156Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in Korea
NCT02047175CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin)
NCT05881707A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 20/1.25mg
NCT06838286Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes
NCT07404735A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846